Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 20340127)

1.

Secreted frizzled-related protein-5 is epigenetically downregulated and functions as a tumor suppressor in kidney cancer.

Kawakami K, Yamamura S, Hirata H, Ueno K, Saini S, Majid S, Tanaka Y, Kawamoto K, Enokida H, Nakagawa M, Dahiya R.

Int J Cancer. 2011 Feb 1;128(3):541-50. doi: 10.1002/ijc.25357.

2.

Functional significance of Wnt inhibitory factor-1 gene in kidney cancer.

Kawakami K, Hirata H, Yamamura S, Kikuno N, Saini S, Majid S, Tanaka Y, Kawamoto K, Enokida H, Nakagawa M, Dahiya R.

Cancer Res. 2009 Nov 15;69(22):8603-10. doi: 10.1158/0008-5472.CAN-09-2534. Epub 2009 Nov 3.

4.

DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines.

Kawamoto K, Hirata H, Kikuno N, Tanaka Y, Nakagawa M, Dahiya R.

Int J Cancer. 2008 Aug 1;123(3):535-42. doi: 10.1002/ijc.23514.

PMID:
18404682
5.

BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer.

Majid S, Dar AA, Ahmad AE, Hirata H, Kawakami K, Shahryari V, Saini S, Tanaka Y, Dahiya AV, Khatri G, Dahiya R.

Carcinogenesis. 2009 Apr;30(4):662-70. doi: 10.1093/carcin/bgp042. Epub 2009 Feb 12.

6.

Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma.

Hirata H, Hinoda Y, Nakajima K, Kawamoto K, Kikuno N, Ueno K, Yamamura S, Zaman MS, Khatri G, Chen Y, Saini S, Majid S, Deng G, Ishii N, Dahiya R.

Int J Cancer. 2011 Apr 15;128(8):1793-803. doi: 10.1002/ijc.25507.

PMID:
20549706
7.

Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.

Urakami S, Shiina H, Enokida H, Hirata H, Kawamoto K, Kawakami T, Kikuno N, Tanaka Y, Majid S, Nakagawa M, Igawa M, Dahiya R.

Clin Cancer Res. 2006 Dec 1;12(23):6989-97.

8.

Functional significance of secreted Frizzled-related protein 1 in metastatic renal cell carcinomas.

Saini S, Liu J, Yamamura S, Majid S, Kawakami K, Hirata H, Dahiya R.

Cancer Res. 2009 Sep 1;69(17):6815-22. doi: 10.1158/0008-5472.CAN-09-1254.

9.

Role of secreted frizzled-related protein 3 in human renal cell carcinoma.

Hirata H, Hinoda Y, Ueno K, Majid S, Saini S, Dahiya R.

Cancer Res. 2010 Mar 1;70(5):1896-905. doi: 10.1158/0008-5472.CAN-09-3549. Epub 2010 Feb 16.

10.

Epigenetic modulation of retinoic acid receptor beta2 by the histone deacetylase inhibitor MS-275 in human renal cell carcinoma.

Wang XF, Qian DZ, Ren M, Kato Y, Wei Y, Zhang L, Fansler Z, Clark D, Nakanishi O, Pili R.

Clin Cancer Res. 2005 May 1;11(9):3535-42.

11.

MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.

Cui L, Zhou H, Zhao H, Zhou Y, Xu R, Xu X, Zheng L, Xue Z, Xia W, Zhang B, Ding T, Cao Y, Tian Z, Shi Q, He X.

BMC Cancer. 2012 Nov 23;12:546. doi: 10.1186/1471-2407-12-546.

12.
13.

Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancer.

Fukui T, Kondo M, Ito G, Maeda O, Sato N, Yoshioka H, Yokoi K, Ueda Y, Shimokata K, Sekido Y.

Oncogene. 2005 Sep 15;24(41):6323-7.

PMID:
16007200
14.

Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma.

Ueno K, Hirata H, Majid S, Chen Y, Zaman MS, Tabatabai ZL, Hinoda Y, Dahiya R.

Mol Carcinog. 2011 Jun;50(6):449-57. doi: 10.1002/mc.20729. Epub 2011 Jan 25.

PMID:
21268126
15.

Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma.

Lv D, Zhao W, Dong D, Qian XP, Zhang Y, Tian XJ, Zhang J.

Eur J Cancer. 2011 Sep;47(13):2068-76. doi: 10.1016/j.ejca.2011.04.021. Epub 2011 May 18.

PMID:
21600761
16.

Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer.

Christoph F, Kempkensteffen C, Weikert S, K├Âllermann J, Krause H, Miller K, Schostak M, Schrader M.

Br J Cancer. 2006 Dec 18;95(12):1701-7. Epub 2006 Nov 28.

17.

Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor.

Shoji S, Tang XY, Umemura S, Itoh J, Takekoshi S, Shima M, Usui Y, Nagata Y, Uchida T, Osamura RY, Terachi T.

Eur Urol. 2009 Feb;55(2):441-9. doi: 10.1016/j.eururo.2008.02.048. Epub 2008 Mar 11.

PMID:
18395325
18.

Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.

Morris MR, Gentle D, Abdulrahman M, Maina EN, Gupta K, Banks RE, Wiesener MS, Kishida T, Yao M, Teh B, Latif F, Maher ER.

Cancer Res. 2005 Jun 1;65(11):4598-606.

19.

Germline and somatic DNA methylation and epigenetic regulation of KILLIN in renal cell carcinoma.

Bennett KL, Campbell R, Ganapathi S, Zhou M, Rini B, Ganapathi R, Neumann HP, Eng C.

Genes Chromosomes Cancer. 2011 Aug;50(8):654-61. doi: 10.1002/gcc.20887. Epub 2011 May 16.

20.

Wnt antagonist gene DKK2 is epigenetically silenced and inhibits renal cancer progression through apoptotic and cell cycle pathways.

Hirata H, Hinoda Y, Nakajima K, Kawamoto K, Kikuno N, Kawakami K, Yamamura S, Ueno K, Majid S, Saini S, Ishii N, Dahiya R.

Clin Cancer Res. 2009 Sep 15;15(18):5678-87. doi: 10.1158/1078-0432.CCR-09-0558.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk